The National Cancer Institute approved the following clinical research studies last month. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in sponsored accounts.Login Subscribe
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Becker’s is thrilled to honor healthcare CNOs. Chief nursing officers are responsible for tackling nurse staffing shortages, managing nursing budgets and more.
round Data: Increasingly, ctDNA is being used for clinical decision-making in a variety of solid malignancies. However, the detection and prognostic value of KRAS ctDNA…
Susan L. Slager, PhD, discussed the etiology and inherited genetic factors that are associated with the risk of chronic lymphocytic leukemia.
For the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA -mutated (g BRCA m or s BRCA m) advanced…
A next-generation sequencing–based molecular assay using urine holds promise for improving the clinical staging of non-metastatic muscle-invasive bladder cancer (MIBC). The assay, the Noninvasive Test…
Angela Hirbe, MD, PhD, discusses the potential significance of MET inhibitors such as mirdametinib for adult and pediatric patients with NF1-PN.
Background IFNs could reprogram immunosuppressive myelopoiesis, induce accumulation of APCs with capacity to prime anti-tumor immunity. IFN-α favors a Th1 shift in immunity and concurrent…
